Online Trading Community for Traders and Investors!
All Blog Posts Tagged 'SVNT' (2)
SMF Notes SVNT Savient Pharma confirms that the FDA approves KRYSTEXXA
Co announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy.
Added by ken flagg on September 15, 2010 at 8:31am — No Comments
SMF Notes SVNT Savient Pharma confirms that the FDA approves KRYSTEXXA
Co announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy.
Added by ken flagg on September 14, 2010 at 9:32pm — No Comments
Latest Blog Posts
Most Popular Blog Posts
Monthly Archives
2013
2012
- December (3)
- November (4)
- October (7)
- September (3)
- August (9)
- July (7)
- June (15)
- May (13)
- April (15)
- March (6)
- February (5)
- January (11)
2011
- December (9)
- November (18)
- October (27)
- September (66)
- August (99)
- July (136)
- June (150)
- May (104)
- April (90)
- March (169)
- February (148)
- January (242)
2010
- December (245)
- November (202)
- October (95)
- September (206)
- August (289)
- July (185)
- June (103)
- May (231)
- April (369)
- March (217)
- February (187)
1999
- November (1)
© 2013 Created by StockMarketFunding.com.
